Skip to main content
OpenTrials
Completed

NCT Number: NCT07442136

Clinical Study to Assess the Efficacy of New Toothpaste Containing SnF as Compared to Colgate Cavity Protection Toothpaste on the Reduction of Enamel Erosion

The goal of this clinical trial is to learn if a new toothpaste can prevent enamel erosion in healthy adults. Researchers will compare the test toothpaste to a control toothpaste to see if there is a difference in erosion levels. Participants will brush twice a day for two minutes with their assigned toothpaste.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

School of Dentistry, University of Texas Health San Antonio

San Antonio, Texas, 78229, United States

About this study

The objective of this clinical study is to assess the efficacy of New Toothpaste Containing SnF as compared to commercially available toothpaste in the reduction of enamel erosion over a ten (10) days period. This investigation will be a randomized, double-blinded, single-center, parallel clinical study. Subjects will be randomly assigned to one of the two study groups, and will be instructed to use their assigned toothpaste for a period of ten (10) days.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Sign an Informed Consent Form;
  • Male or female 18 to 70 years of age, inclusive;
  • Be in good general health as determined by the study investigators;
  • Available for the eighteen (18) days duration of the study;
  • Have normal salivary flow rate (stimulated and unstimulated flow of ≥0.7 ml/min and ≥0.2 ml/min respectively) ascertained from a preliminary saliva examination;
  • Have healthy salivary pH (unstimulated saliva pH 6.8-7.8) ascertained from a preliminary saliva test;
  • Must be able to accept a well-fitting removable intraoral appliance bearing at least two enamel specimens.

Exclusion criteria

  • Gross oral pathology, chronic disease, and/or history of allergies to any of the test products;
  • Use of a desensitizing oral care product and/or recipient of any dental desensitizing treatment within the past three months prior to start of the study;
  • Advanced periodontal disease and/or treatment for periodontal disease (including surgery) within the past twelve months;
  • Obvious signs of dental erosion Teeth with extensive/defective restorations (including prosthetic crowns), suspected pulpitis, caries, cracked enamel, or used as abutments for removable partial dentures;
  • Current use of anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory drugs, daily use of analgesics, or medication which alters salivary flow
  • Participation in any other oral clinical study for the duration of this study
  • Self-reported pregnancy and/or currently breastfeeding;
  • Allergies to oral care products, personal care consumer products, and/or their ingredients;
  • Medical condition which prohibits not eating/drinking for 4 hours.

Treatment and study plan

New Toothpaste Containing SnF

Drug

Participants will brush with a new toothpaste containing SnF for two minutes twice daily.

Fluoride Toothpaste

Drug

Participants will brush with a regular fluoride toothpaste twice daily for two minutes.

Primary outcomes

  1. Surface loss

    Time frame: From baseline to the end of treatment at 10 days.

    Depth of surface loss in an enamel block worn on a dental retainer by the participant, as determined by an optical profilometer.

Sponsors and collaborators

Lead sponsor

Colgate Palmolive

Industry

Collaborators

  • The University of Texas Health Science Center at San Antonio

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Mar 2, 2026
Registry last updated
Jul 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.